• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哈格曼因子系统接触相中的分子组装。

Molecular assembly in the contact phase of the Hageman factor system.

作者信息

Cochrane C G, Griffin J H

出版信息

Am J Med. 1979 Oct;67(4):657-64. doi: 10.1016/0002-9343(79)90253-5.

DOI:10.1016/0002-9343(79)90253-5
PMID:386794
Abstract

Data obtained in the past few years have defined the molecular mechanisms of contact activation of the Hageman factor pathways of plasma, i.e., the kinin-forming, intrinsic clotting and fibrinolytic systems. Involved are four molecules: Hageman factor, high molecular weight (MW) kininogen, prekallikrein and factor XI. High MW kininogen serves as a surface cofactor to assemble prekallikrein or factor XI in proximity to surface-bound Hageman factor. Reciprocal proteolytic activation of Hageman factor and prekallikrein represents an essential step in the rapid activation of the contact phase. Although Hageman factor does undergo cleavage and activation in the absence of prekallikrein or high MW kininogen, the rate is approximately 50 and 100 times slower than when these molecules are present. Once Hageman factor is activated on the surface, it cleaves and activates clotting factor XI. Activated Hageman factor (HFa) exhibits two molecular forms. One of these, alpha HFa, activates prekallikrein and factor XI, and the intrinsic clotting system on the surface. alpha HFa and clotting factor XI remain surface bound. The other form of activated Hageman factor, beta HFa, leaves the surface, going into solution where it readily activates additional prekallikrein but not factor XI. Of perhaps even greater importance, kallikrein rapidly dissociates from the surface. Thus the formation of bradykinin and fibrinolysis is disseminated whereas clotting via the intrinsic system remains localized. Reviewed here is the molecular mechanism of contact activation of the Hageman factor pathways and discussed in the interaction of Hageman factor with the negatively charged surface, prekallikrein, factor XI and high MW kininogen. The multiple forms of activated Hageman factor and their potential biologic significance are also discussed.

摘要

过去几年获得的数据已明确了血浆中Hageman因子途径(即激肽形成系统、内源性凝血系统和纤维蛋白溶解系统)接触激活的分子机制。涉及的四种分子为:Hageman因子、高分子量(MW)激肽原、前激肽释放酶和因子XI。高分子量激肽原作为一种表面辅因子,在与表面结合的Hageman因子附近组装前激肽释放酶或因子XI。Hageman因子和前激肽释放酶的相互蛋白水解激活是接触相快速激活的关键步骤。虽然在没有前激肽释放酶或高分子量激肽原的情况下,Hageman因子确实会发生裂解和激活,但其速率比这些分子存在时慢约50倍和100倍。一旦Hageman因子在表面被激活,它就会裂解并激活凝血因子XI。激活的Hageman因子(HFa)呈现两种分子形式。其中一种,α-HFa,激活前激肽释放酶和因子XI以及表面的内源性凝血系统。α-HFa和凝血因子XI仍与表面结合。激活的Hageman因子的另一种形式,β-HFa,离开表面进入溶液,在其中它很容易激活额外的前激肽释放酶,但不能激活因子XI。也许更重要的是,激肽释放酶迅速从表面解离。因此,缓激肽的形成和纤维蛋白溶解得以扩散,而内源性系统的凝血仍局限于局部。本文综述了Hageman因子途径接触激活的分子机制,并讨论了Hageman因子与带负电荷表面、前激肽释放酶、因子XI和高分子量激肽原的相互作用。还讨论了激活的Hageman因子的多种形式及其潜在的生物学意义。

相似文献

1
Molecular assembly in the contact phase of the Hageman factor system.哈格曼因子系统接触相中的分子组装。
Am J Med. 1979 Oct;67(4):657-64. doi: 10.1016/0002-9343(79)90253-5.
2
Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.高分子量激肽原在凝血因子XI和前激肽释放酶的表面结合及激活中的作用。
Proc Natl Acad Sci U S A. 1977 Oct;74(10):4636-40. doi: 10.1073/pnas.74.10.4636.
3
Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.人凝血因子Ⅻ的激活与功能。高分子量激肽原和前激肽释放酶的作用。
J Clin Invest. 1977 Jul;60(1):18-31. doi: 10.1172/JCI108754.
4
Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.哈格曼因子依赖性途径:启动机制与缓激肽形成
Fed Proc. 1983 Nov;42(14):3123-7.
5
Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.血浆接触激活过程中产生的两种活化哈格曼因子形式的表面活性和液相活性。
J Exp Med. 1978 Mar 1;147(3):719-29. doi: 10.1084/jem.147.3.719.
6
Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.高分子量激肽原参与哈格曼因子表面依赖性反应的机制。
Proc Natl Acad Sci U S A. 1976 Aug;73(8):2554-8. doi: 10.1073/pnas.73.8.2554.
7
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.接触激活过程中人类凝血因子Ⅻ的结合与裂解特性。正常血浆与缺乏因子Ⅺ、前激肽释放酶或高分子量激肽原的血浆的比较。
J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741.
8
Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.哈格曼因子激活机制及高分子量激肽原作为凝血辅因子的作用。
Ann N Y Acad Sci. 1981;370:253-60. doi: 10.1111/j.1749-6632.1981.tb29738.x.
9
Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.高分子量激肽原对哈格曼因子片段功能的增强作用。
J Clin Invest. 1977 Jul;60(1):7-17. doi: 10.1172/JCI108770.
10
Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.人类内源性凝血和纤维蛋白溶解途径的启动:表面、哈格曼因子、前激肽释放酶、高分子量激肽原和因子XI的作用。
Prog Hemost Thromb. 1978;4:127-75.

引用本文的文献

1
Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems.糖化白蛋白调节接触系统,影响激肽释放酶-激肽系统和内在凝血系统。
J Thromb Haemost. 2023 Apr;21(4):814-827. doi: 10.1016/j.jtha.2022.12.015. Epub 2022 Dec 27.
2
A comparison of blood factor XII autoactivation in buffer, protein cocktail, serum, and plasma solutions.缓冲液、蛋白鸡尾酒、血清和血浆溶液中血液因子 XII 自动激活的比较。
Biomaterials. 2013 Jan;34(3):607-20. doi: 10.1016/j.biomaterials.2012.09.034. Epub 2012 Oct 30.
3
Antithrombotic therapy in acute coronary syndrome: how far up the coagulation cascade will we go?
急性冠状动脉综合征的抗血栓治疗:我们将在凝血级联反应中走多远?
Curr Cardiol Rep. 2010 Jul;12(4):315-20. doi: 10.1007/s11886-010-0117-6.
4
Human plasma kallikrein-kinin system: physiological and biochemical parameters.人血浆激肽释放酶-激肽系统:生理和生化参数
Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):234-50. doi: 10.2174/187152509789105444.
5
A protease-like permeability factor in guinea pig skin: immunologic identity with plasma Hageman factor.豚鼠皮肤中一种类似蛋白酶的通透因子:与血浆哈格曼因子的免疫同一性。
Am J Pathol. 1982 May;107(2):127-34.
6
Studies on the pathogenesis of the adult respiratory distress syndrome.成人呼吸窘迫综合征发病机制的研究。
J Clin Invest. 1982 Mar;69(3):543-53. doi: 10.1172/jci110480.
7
Guinea pig plasma kallikrein as a vascular permeability enhancement factor. Its dependence on kinin generation and regulation mechanisms in vivo.豚鼠血浆激肽释放酶作为一种血管通透性增强因子。其对体内激肽生成及调节机制的依赖性。
Am J Pathol. 1984 Apr;115(1):92-101.
8
Overview: pharmacology of ticlopidine.概述:噻氯匹定的药理学
Agents Actions Suppl. 1984;15:108-15. doi: 10.1007/BF01966992.
9
Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.人、牛和兔血浆中的前激肽释放酶激活:牛血浆中存在一种抑制剂。
Inflammation. 1992 Jun;16(3):205-13. doi: 10.1007/BF00918810.
10
Fibrinogen blocks the autoactivation and thrombin-mediated activation of factor XI on dextran sulfate.纤维蛋白原可阻断硫酸葡聚糖上因子 XI 的自身激活以及凝血酶介导的激活。
Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11189-93. doi: 10.1073/pnas.89.23.11189.